Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of liraglutide versus lifestyle counselling on subcutaneous and visceral fat distribution, liver steatosis, insulin sensitivity and beta-cell function after weight loss in metformin-treated obese patients with impaired glucose tolerance, impaired fasting glucose or newly diagnosed type 2 diabetes mellitus

Next Previous
Trial Profile

Effects of liraglutide versus lifestyle counselling on subcutaneous and visceral fat distribution, liver steatosis, insulin sensitivity and beta-cell function after weight loss in metformin-treated obese patients with impaired glucose tolerance, impaired fasting glucose or newly diagnosed type 2 diabetes mellitus

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Glucose intolerance; Glucose metabolism disorders; Type 2 diabetes mellitus
  • Focus Therapeutic Use

    • Most Recent Events

    • 14 Sep 2017 Primary endpoint of change in VAT after achievement of theweight loss target has been met, according to results published in the Diabetes Care.
    • 14 Sep 2017 Results published in the Diabetes Care
    • 21 Oct 2015 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top